Mr. Osvaldo (Ozzie) Iadarola reports,

KAMLOOPS, B.C. – Audiotech Healthcare Corporation (AUD:TSX Venture Exchange) is pleased to announce that negotiations with respect to Audiotech’s proposed acquisition of a 25% equity interest in Lobe Purchasing Group Inc. are proceeding. The closing of the transaction, which was originally expected to occur on or before February 28, 2005, has been extended. The transaction is now expected to close on or before April 15, 2005.

Both parties requested the extension as a greater number of documents than originally expected have had to be translated from French to English and it took longer than anticipated for the translation to be completed. Further, Audiotech and Lobe management are jointly exploring avenues in which the scope of the association of the two entities can be expanded to enhance the growth of both organizations. Audiotech is now in possession of all required documentation to complete its due diligence review and is pleased to announce that nothing has yet come to management’s attention to suggest that the transaction will not proceed in accordance with the original terms.

Lobe Purchasing Group Inc. manages a buying group composed of 15 hearing care clinics in Eastern Canada, making it the largest hearing product provider in the region. Management believes that the union of Audiotech and Lobe under the proposed agreement brings several advantages to both companies. Most notably, it creates the platform to commence the joint creation of a truly national network of hearing care clinics. Whereas Audiotech's existing geographic focus is Western Canada, Lobe's existing clinic network and managerial experience lies in Eastern Canadian markets including Ontario and Quebec.

The acquisition remains subject to a number of conditions, including the satisfactory outcome of the financial and operational due diligence process to be completed by Audiotech, the negotiation of a definitive agreement, and the receipt of all necessary regulatory approvals.

The company's shares are listed and posted for trading on Tier 1 of the TSX Venture exchange under the symbol "AUD." For more information on the company, contact Osvaldo (Ozzie) Iadarola, President & CEO, at (250) 372-5847, or Doren Quniton of QIS Capital, investor relations, at (250) 376-8989, or visit the company's website at www.audiotech.org.

AUDIOTECH HEALTHCARE CORPORATION
First Bank Building
760-175 Second Avenue
Kamloops, B.C. V2C 5W1
Phone: (250) 372-5847
Fax: (250) 372-3859
Email: info@audiotech.org

Except for historical information contained herein this document contains forward-looking statements. These statements contain known and unknown risks and uncertainties that may cause the company's actual results or outcomes to be materially different from those anticipated and discussed herein.